Product Added to Cart!
$373.90

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI31337_100_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
O-(Tetrahydropyran-2-yl)hydroxylamine
Brand Name
Chem Impex
Product Number
31337
CAS
6723-30-4
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
5142091
IUPAC Name
O-(oxan-2-yl)hydroxylamine
InChI Key
NLXXVSKHVGDQAT-UHFFFAOYSA-N
SMILES
C1CCOC(C1)ON

Description

O-(Tetrahydropyran-2-yl)hydroxylamine is widely utilized in research focused on:

Synthesis of Pharmaceuticals: This compound serves as a key intermediate in the synthesis of various pharmaceutical agents, particularly in the development of drugs targeting neurological disorders.

Organic Synthesis: It is employed in organic chemistry for the preparation of oximes, which are crucial for the synthesis of amines and other nitrogen-containing compounds.

Analytical Chemistry: The compound is used in analytical methods to detect and quantify carbonyl compounds, enhancing the accuracy of chemical analyses in laboratories.

Bioconjugation: It plays a role in bioconjugation processes, allowing researchers to attach biomolecules to surfaces or other molecules, which is essential in drug delivery systems.

Polymer Chemistry: This chemical is utilized in the modification of polymers, improving their properties for specific applications in materials science and engineering.

References Data Source From Pubchem

Design, synthesis and biological evaluation of novel hydroxamic acids bearing coumarin moieties as histone deacetylase inhibitors and cytotoxic agents

Publication Name: Medicinal Chemistry Research
Publication Date: 2025-11-27
DOI: 10.1007/s00044-025-03509-y

Synthetic account on indoles and their analogues as potential anti-plasmodial agents

Publication Name: Molecular Diversity
Publication Date: 2024-05-06
DOI: 10.1007/s11030-024-10842-8

Dual HDAC–BRD4 inhibitors endowed with antitumor and antihyperalgesic activity

Publication Name: Medicinal Chemistry Research
Publication Date: 2022-05-03
DOI: 10.1007/s00044-022-02896-w

Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target

Publication Name: Nature Chemical Biology
Publication Date: 2022-04-28
DOI: 10.1038/s41589-022-01015-5

Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid

Publication Name: EJNMMI Radiopharmacy and Chemistry
Publication Date: 2018-07-27
DOI: 10.1186/s41181-018-0045-0